The US Senate plans to move forward with the FDA Reauthorization Act, which would reauthorize medical device user fees through fiscal year 2022, on Aug. 3, according to Senate Majority Leader Mitch McConnell, R-Kent.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?